Womelsdorf Dr John Francis 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed Dec 26, 2006
Insider Transaction Report
Form 4
Womelsdorf Dr John Francis
VP, Business Development
Transactions
- Award
Option
2006-12-21+50,000→ 50,000 totalExercise: $6.95Exp: 2016-12-20→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]These options are exercisable over a four-year period with one-quarter (1/4) of the options granted vesting on December 12, 2007, the first anniversary of the grant date, and 1/48 of the balance of the options granted vesting monthly thereafter.